Overview and Application Analysis of Cyclophosphamide

Cyclophosphamide is a widely used clinical immunosuppressant and anti-tumor drug. It mainly inhibits cell proliferation by interfering with DNA synthesis. This article will start from the dimensions of its pharmacological effects, indications, adverse reactions and manufacturers, focusing on analyzing its core value in tumor treatment and autoimmune diseases, while taking into account the safety precautions for medication. The content structure is divided into: pharmacological mechanism (main), clinical application (main), side effect management (secondary) and market product information (secondary) to help readers systematically understand the drug.

Pharmacological effects and therapeutic mechanisms

Cyclophosphamide belongs toAlkylating agentsThe drug, through metabolic activation, forms phosphoramide mustard, which cross-links with DNA chains to block replication, thereby inhibiting the proliferation of tumor cells or overactive immune cells. Its unique prodrug design (which requires activation by liver CYP450 enzymes) reduces direct toxicity, but individual differences in metabolism may affect efficacy. In the field of tumors, it shows significant activity in lymphoma, leukemia, etc.; in autoimmune diseases (such as systemic lupus erythematosus), it plays a role by regulating B cell function.

Clinical applications and indications

The indications of cyclophosphamide cover many types of diseases.tumor treatmentIt is its primary use, especially effective for solid tumors such as non-Hodgkin lymphoma and breast cancer. inNon-oncology areas, low-dose regimens are often used for severe rheumatoid arthritis or vasculitis. During clinical use, the patient's liver and kidney function must be strictly assessed and combined with hydration therapy to reduce the risk of bladder toxicity. Some studies (such as data from the National Cancer Institute) suggest that its combination with glucocorticoids can improve the remission rate of lupus nephritis.

Adverse reactions and risk management

Common side effects of this drug include bone marrow suppression (requires regular blood routine monitoring), hemorrhagic cystitis (preventable with mesna), and long-term reproductive toxicity. Elderly patients or long-term users need to be alert to the risk of secondary malignant tumors. Live vaccinations should be avoided during treatment and signs of infection should be closely monitored. The 2015 "Chinese Pharmacopoeia" clearly states that its contraindications include severe active infection and pregnant women.

Summary and Product Information

Cyclophosphamide is a classic chemotherapy drug, and the key is to balance efficacy and safety. Patients need to take individualized medication under the guidance of professional physicians and cooperate with auxiliary treatment to reduce side effects. Major domestic manufacturers include Hengrui Pharmaceuticals, Qilu Pharmaceuticals, etc. Specific product information is shown in the table below:

Quote sources:
1. National Cancer Institute (NCI) "Guidelines for the Anti-tumor Use of Cyclophosphamide"
2. "Chinese Pharmacopoeia" 2020 Edition Part 2
3. Official product instructions of Hengrui Pharmaceutical and Qilu Pharmaceutical